ARTES and Burnet Institute Join Forces to Develop Novel Hepatitis C Vaccine
Langenfeld, Germany /Melbourne, Australia July 26, 2016 / B3C newswire / -- ARTES Biotechnology and Burnet Institute announce they have joined forces to develop a novel, effective vaccine to prevent transmission of hepatitis C virus (HCV). An HCV vaccine …